Patents Examined by Philip R Wiest
  • Patent number: 11969542
    Abstract: In some examples, provided is a fluid blockage device for use with a reduced-pressure source for treating a tissue site with reduced pressure. The fluid blockage device may be configured to preclude fluid communication through a port fluidly coupled to the reduced-pressure source when the fluid blockage device contacts a liquid. Other devices, systems, and methods are disclosed.
    Type: Grant
    Filed: June 22, 2023
    Date of Patent: April 30, 2024
    Assignee: KCI Licensing, Inc.
    Inventors: Christopher Brian Locke, Benjamin A. Pratt
  • Patent number: 11969529
    Abstract: The exemplary systems and methods may generate treatment records for extracorporeal blood treatments. The treatment records may include a plurality of values of various parameters. The various parameters may include a compulsory set of parameters that are preset, a dependent set of parameters that a dependent on one or more of a selected treatment and a system configuration, and a discretionary set of parameters that are selected by a user.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: April 30, 2024
    Assignee: Gambro Lundia AB
    Inventors: Roger Nilsson, Roland Persson, Bendik Torvin
  • Patent number: 11964091
    Abstract: A method and system for performing transseptal extracorporeal membrane oxygenation is disclosed. The method may include puncturing a septum between the right atrium and the left atrium and advancing a catheter system through the puncture and into the aorta. A first portion of the catheter system can remove blood from the patient, in some examples near the inferior vena cava. A second portion can return oxygenated blood to the patient, through the transseptal puncture and into the aorta.
    Type: Grant
    Filed: October 10, 2023
    Date of Patent: April 23, 2024
    Assignee: Vantis Vascular, Inc.
    Inventors: Tim A. Fischell, Frank Saltiel, Jeffrey Payne
  • Patent number: 11957820
    Abstract: A blood pump is disclosed. The blood pump apparatus is arranged to provide pulsatile flow, and comprises a flexible inner cylindrical duct providing a blood flow region, and an outer cylindrical duct arranged to surround the inner cylindrical duct and arranged to accommodate a pumping fluid. In the pump the inner cylindrical duct is described as comprising a blood inlet for receiving blood into the region, a blood outlet for passing blood out from the blood flow region and a passageway therebetween. There is also described the feature of the inner duct comprising a non return valve at the blood inlet and a non return valve at the blood outlet, the outer cylindrical duct having a fluid port for a pumping fluid, and a pump device arranged to cyclically deliver and withdraw pumping fluid to the fluid port thereby cyclically compressing and expanding the flexible inner cylindrical duct urging blood through the blood flow region and delivering a pulsating blood flow through the blood outlet.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: April 16, 2024
    Assignee: Haemaflow Limited
    Inventors: William Richard Johns, Ronald Kelvin Knight
  • Patent number: 11951038
    Abstract: Lacrimal implants for treating diseases or disorders are disclosed. More particularly, lacrimal implants, methods of making such implants, and methods of treating ocular, respiration, inner ear or other diseases or disorders using such implants are disclosed.
    Type: Grant
    Filed: October 7, 2019
    Date of Patent: April 9, 2024
    Assignee: Mati Therapeutics Inc.
    Inventors: Alan R. Rapacki, Valery Rubinchik, John B. Holds, Sylvie Sim, Danny Shen
  • Patent number: 11951270
    Abstract: Systems and methods for implanting an endovascular shunt in a patient is disclosed. The system having an expandable anchor configured for being deployed in a dural venous sinus of a patient at a location distal to a curved portion of a wall of an inferior petrosal sinus (IPS) of the patient; an elongate guide member coupled to, and extending proximally from, the anchor; a shunt delivery catheter having a first lumen configured to receive the guide member, and a second lumen extending between respective proximal and distal openings in the shunt delivery catheter, the shunt delivery catheter further having a penetrating element coupled to a distal end of the catheter; and the system further having a guard at least partially disposed over, and movable relative to, the penetrating element.
    Type: Grant
    Filed: August 5, 2020
    Date of Patent: April 9, 2024
    Assignee: CereVasc, LLC
    Inventors: Adel M. Malek, Carl Heilman, David A. Rezac, Jack B. Sattell, Anthony Maiorano
  • Patent number: 11944772
    Abstract: A wound therapy device includes a wound dressing and a humidifier configured to deliver humid air to a wound site to which the wound dressing is applied. The humidifier may be a remote structure that is fluidly connected to the wound dressing applied about a patient's skin at a wound site. Alternatively, the humidified may be integrated with the wound dressing to define an integral, portable therapy device that may be worn by the patient. The wound therapy device may be a standalone wound treatment device, or may be used in conjunction with other wound treatment devices, such as, e.g., negative pressure wound therapy devices.
    Type: Grant
    Filed: May 11, 2020
    Date of Patent: April 2, 2024
    Assignee: Solventum Intellectual Properties Company
    Inventor: Teryl Blane Sanders
  • Patent number: 11938254
    Abstract: The present invention provides a hollow fiber membrane oxygenator comprising a housing comprising a blood flow path; a blood inlet port and a blood outlet port disposed in the housing so as to allow blood to flow through the blood flow path; a gas exchange part comprising a bundle of a plurality of hollow fiber membranes disposed in the blood flow path, a gas inflow port and a gas outflow port provided in the housing so as to allow an oxygen-containing gas to flow through lumens of the hollow fiber membranes, and a gas temperature control part for adjusting the temperature of a gas flowing through the lumens of the hollow fiber membranes.
    Type: Grant
    Filed: March 26, 2019
    Date of Patent: March 26, 2024
    Assignee: NATIONAL UNIVERSITY CORPORATION SHIMANE UNIVERSITY
    Inventor: Teiji Oda
  • Patent number: 11925743
    Abstract: Described are embodiments that include methods and devices for separating components from multi-component fluids. Embodiments may involve use of separation vessels and movement of components into and out of separation vessels through ports. Embodiments may involve the separation of plasma from whole blood. Also described are embodiments that include methods and devices for positioning portions, e.g., loops, of disposables in medical devices. Embodiments may involve use of surfaces for automatically guiding loops to position them into a predetermined position.
    Type: Grant
    Filed: January 30, 2023
    Date of Patent: March 12, 2024
    Assignee: Terumo BCT, Inc.
    Inventors: Thomas J. Felt, Dennis J. Hlavinka, Brian M. Holmes
  • Patent number: 11925599
    Abstract: A container for transporting and/or processing a biopharmaceutical fluid, the container comprising a wall, the wall comprising a shape memory material being adapted to change shape when induced by an external stimulus, so that the container can be alternately in a collapsed state and in an unfolded state, the wall of the container in the unfolded state delimiting an internal cavity adapted to contain the biopharmaceutical fluid.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: March 12, 2024
    Assignee: SARTORIUS STEDIM FMT SAS.
    Inventors: Stefan Schlack, Jean-Marc Cappia
  • Patent number: 11918507
    Abstract: A monitor device and an ostomy system comprising a monitor device (6) and an ostomy appliance (2) is disclosed, the ostomy appliance including a base plate (4), the base plate having a first adhesive layer with a proximal side configured for attachment of the base plate to the skin surface of a user, the first adhesive layer having a stomal opening (18) with a center point, the monitor device comprising a processor and a sensor unit comprising a first sensor with a first sensor surface accommodated in a monitor device housing, the monitor device housing having a sensor opening in a proximal surface of the monitor device, the sensor opening forming at least a part of a sensor path from surroundings of the proximal surface to the first sensor surface.
    Type: Grant
    Filed: February 5, 2019
    Date of Patent: March 5, 2024
    Assignee: Coloplast A/S
    Inventors: Jais Ask Hansen, Finn Speiermann, Lars Erup Larsen, Niels Hvid
  • Patent number: 11904120
    Abstract: Methods and devices that prevent stasis in the LAA by either increasing the flow through the LAA or by closing off or sealing the LAA. Increasing the flow is accomplished through shunts, flow diverters, agitators, or by increasing the size of the ostium. Closing off the LAA is accomplished using seals or by cinching the LAA.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: February 20, 2024
    Assignee: NXT Biomedical, LLC
    Inventors: Glen Rabito, Joseph Passman, Robert C. Taft, Stanton J. Rowe, Robert S. Schwartz, Alexander Siegel
  • Patent number: 11904080
    Abstract: Systems, methods, and devices are provided for the treatment of edema. In one aspect a method for implanting an indwelling catheter within a vein of a patient is provided. The catheter can extend from a position upstream of at least one outflow port of a duct of the lymph system to a terminal position downstream of the at least one outflow port. In use, a first restriction can be created within the vein proximal to a distal region of the catheter. The first restriction can define a localized low pressure zone distal of the restriction and within a portion of the vein housing the catheter. The low pressure zone can be adjacent to the at least one outflow port to enable fluid to pass from the at least one lymph duct outflow port into the vein.
    Type: Grant
    Filed: March 10, 2020
    Date of Patent: February 20, 2024
    Assignee: White Swell Medical Ltd
    Inventors: Yaacov Nitzan, Menashe Yacoby, Tanhum Feld
  • Patent number: 11896753
    Abstract: A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and administering the third filtrate to the subject.
    Type: Grant
    Filed: March 3, 2020
    Date of Patent: February 13, 2024
    Assignee: Immutrix Therapeutics, Inc.
    Inventors: Carol A. Rae, Jan Simoni, Grace Simoni, John F. Moeller
  • Patent number: 11883571
    Abstract: An extracorporeal blood treatment apparatus includes a filtration unit (2) connected to a blood circuit (17) and a dialysate circuit (32), a preparation device (9) for preparing and regulating the composition of the dialysis fluid, and a sensor (11) for measuring conductivity of the dialysate (i.e. spent dialysis fluid); a control unit (12) configured for setting a sodium concentration in the dialysis fluid and after setting the dialysis fluid at the initial set point, circulating the dialysis fluid and blood through the filtration unit (2), measuring an initial conductivity value of the dialysate at the beginning of the treatment, and calculating, based on the measured initial conductivity value and on the corresponding conductivity value of the dialysis fluid, the value of the initial plasma conductivity, said circulating of the dialysis fluid up to the calculating of the initial plasma conductivity performed by maintaining the dialysis fluid conductivity substantially constant.
    Type: Grant
    Filed: April 15, 2020
    Date of Patent: January 30, 2024
    Assignee: Gambro Lundia AB
    Inventors: Paolo Rovatti, Alessandro Surace, Carlo Alberto Lodi, Anders Wallenborg, Anders Nilsson, Kristian Solem, Jan Sternby, Thomas Hertz
  • Patent number: 11883589
    Abstract: A tracheostomy tube monitor and alerting apparatus includes: (i) a passive humidification device; and (ii) an integrated monitoring assembly fitted in an opening of a rear sidewall of the passive humidification device. The passive humidification device is configured to be connected to a connector of a tracheostomy tube of a patient. Once connected, the monitoring assembly of the apparatus can begin measuring one or more physiological parameters, such as, air flow, oxygen level, carbon dioxide level, pressure, and moisture. The measurements are compared against threshold values that denote blockage or decannulation. When these threshold values are surpassed, an alarm is actuated to alert a caregiver that the patient may be experiencing obstruction or decannulation of the tracheostomy tube.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: January 30, 2024
    Inventor: Deepak Kumar Mehta
  • Patent number: 11883364
    Abstract: A sealing element is received between a connector and an attachment member. The sealing element includes a foot section received by a recess of the connector, a shoulder engaging an inner surface of the attachment member, and a flange engaging a support surface of the connector. The sealing element also includes a cylindrical body extending from the shoulder to the flange along an insertion direction and, where the cylindrical body deforms to create a flow path through the sealing element, and a sealing head defines an opening that transitions from a closed state to an open state when the cylindrical body deforms.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: January 30, 2024
    Assignee: Fresenius Kabi Deutschland Gmbh
    Inventor: Torsten Brandenburger
  • Patent number: 11883597
    Abstract: The invention relates to a respiratory mask (1) having a mask unit (2) and having an emission device (3) for discharging exhaled gas from the respiratory mask (1). The mask unit (2) comprises a mask body (4) and a connection unit (5) which can be connected to the mask body (4) for connection of a respiratory gas feed line (101). The emission device (3) comprises a plurality of flow channels (6), which are arranged in at least one part of the mask unit (2). Here the emission device (3) comprises at least one flow channel.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: January 30, 2024
    Assignee: LOEWENSTEIN MEDICAL TECHNOLOGY S.A.
    Inventor: Martin Eifler
  • Patent number: 11878115
    Abstract: Provided herein are devices, systems, and methods for providing respiratory therapy to a patient using a nasal cannula comprising a cannula body, first and second inlet tubes, and a nasal prong for the delivery of a flow of breathing gas to the patient. Configured with the cannula is a nebulizer having an aerosol generator positioned to emit aerosolized medicament along a longitudinal axis of the nasal prong. A flow director is configured to direct the flow of breathing gas into the nasal prong such that the breathing gas flows along the longitudinal axis, such that the flow of aerosolized medicament is contained within the flow of breathing gas as it moves along the longitudinal axis of the nasal prong for delivery to the patient.
    Type: Grant
    Filed: September 25, 2020
    Date of Patent: January 23, 2024
    Assignee: VAPOTHERM, INC.
    Inventor: Scott A. Leonard
  • Patent number: 11865063
    Abstract: According to the disclosure there is provided an apparatus that assesses chest recoil of a subject during cardio pulmonary resuscitation (CPR) carried out by a rescuer on the subject and provides feedback to the rescuer. This apparatus may include a bio-signal measurement system configured to measure bio-signals of the subject. The apparatus may identify when CPR is required and may provide a CPR start signal to indicate when CPR should be started and this apparatus may identify when CPR is to be ceased. A CPR stop signal may be provided to a rescuer to indicate when CPR should be stopped. The apparatus may include electronic circuits capable of measuring impedance signals of the subject, may include sensors that sense bio-signals, and may include defibrillator shock electronics capable of providing a shock to the subject to restart or reset the heart of the subject.
    Type: Grant
    Filed: February 22, 2021
    Date of Patent: January 9, 2024
    Assignee: HeartSine Technologies Limited
    Inventors: Dymphna Mary Donaghy, Johnny Houston Anderson, Olibhear Oisin Gerard McAlister, Adam Patrick Harvey